On Holding AG (ONON)

Key Updates

On Holding AG advanced 2.79% to $37.55 as of May 18th, extending the recovery pattern that began on May 13th to a cumulative 16.8% gain over six trading sessions. The rally continues despite the absence of immediate catalysts, with the most recent news from April 25th detailing the company's strategic expansion and leadership transition. The stock remains under pressure year-to-date with a -19.21% decline, though the recent 10.31% five-day surge suggests potential stabilization after testing lower support levels.

Current Trend

ONON exhibits a bearish year-to-date trajectory with a -19.21% decline through May 18th, reflecting significant pressure on premium athletic footwear valuations in 2026. However, the recent technical reversal from the May 12th low has produced six consecutive sessions of gains totaling 16.8%, representing the strongest recovery period since the YTD decline began. The six-month performance of -11.98% indicates sustained headwinds, while the one-month gain of 1.62% demonstrates recent stabilization. Current price action at $37.55 suggests the stock is attempting to establish a new support base following the sharp recovery from the $32.17 level reached on May 12th.

Investment Thesis

On Holding's investment case centers on its ability to scale from $3.8 billion in annual sales while preserving its premium performance positioning and avoiding the brand dilution that has impacted competitors including Nike and Allbirds. The company's aggressive innovation investment—expanding R&D from 30 employees in early 2020 to over 550 currently—demonstrates commitment to technological differentiation. The dual-CEO leadership structure implemented to maintain "entrepreneurial speed" during rapid expansion represents an organizational response to scaling challenges. The South Korean factory opening for LightSpray technology production signals vertical integration in advanced manufacturing. The core thesis depends on On's capacity to execute mainstream expansion through celebrity collaborations (Zendaya, Roger Federer) and apparel diversification without compromising the performance credentials that justify premium pricing.

Thesis Status

The investment thesis remains intact but faces heightened execution risk. The -19.21% YTD decline reflects market skepticism about On's ability to navigate the growth-versus-authenticity balance, a challenge explicitly acknowledged in the April 25th New York Times analysis. The tripling of workforce since NYSE listing and portfolio expansion beyond core running shoes represent the scaling phase where brand dilution risks materialize. However, the 550-person R&D team and LightSpray factory investment demonstrate tangible commitment to innovation-led differentiation. The recent 16.8% recovery suggests investors are reassessing the valuation following the YTD selloff, potentially viewing current levels as attractive relative to the company's $3.8 billion revenue base and growth trajectory. The thesis requires monitoring of same-store sales trends, brand perception metrics among core performance athletes, and margin sustainability as the company expands distribution.

Key Drivers

Leadership transition to dual-CEO structure represents the primary organizational driver, designed to preserve decision-making agility while managing a significantly larger enterprise than at founding. The expansion strategy encompasses three vectors: geographic distribution growth, product category diversification into apparel, and celebrity partnerships for mainstream appeal. R&D investment scaling from 30 to 550+ employees signals innovation as the central competitive moat, with LightSpray technology and the dedicated South Korean production facility representing tangible outputs. The competitive landscape driver involves positioning relative to Nike's challenges and Allbirds' struggles, creating both opportunity and cautionary precedent. Market-wide factors include premium athletic footwear demand elasticity and consumer willingness to sustain spending on $150+ running shoes amid broader economic conditions.

Technical Analysis

ONON has established a clear reversal pattern from the $32.17 low reached on May 12th, with six consecutive advancing sessions producing a 16.8% cumulative gain to $37.55. The recovery has proceeded in measured increments (5.00%, 4.55%, 3.28%, 2.79%), suggesting accumulation rather than speculative momentum. Resistance likely exists at the $40-42 range, representing the one-month high area prior to the recent decline. The -19.21% YTD performance indicates the stock remains well below the 2026 opening level, with significant overhead supply likely present. Volume patterns during the recovery (not provided in data) would be critical to assess sustainability. The six-month decline of -11.98% suggests a longer-term downtrend that requires sustained buying pressure to reverse. Current price action suggests a retest of the $38-40 range is probable if momentum continues, though the YTD decline indicates substantial resistance before approaching breakeven levels.

Bull Case

• Massive R&D scaling demonstrates innovation commitment: Expansion from 30 to 550+ R&D employees with dedicated LightSpray manufacturing facility positions On for technological differentiation in a commoditizing market, supporting premium pricing power. Source
• $3.8 billion revenue base provides scaling advantages: Achieved revenue scale enables marketing investments, supply chain leverage, and retail partnerships that smaller competitors cannot match while maintaining premium positioning. Source
• Strategic celebrity partnerships expand addressable market: Collaborations with Zendaya and Roger Federer provide mainstream visibility and lifestyle positioning beyond core performance segment, driving revenue diversification. Source
• Competitors' struggles create market share opportunity: Explicit positioning relative to Nike's challenges and Allbirds' difficulties suggests On can capture share from faltering premium athletic brands. Source
• Technical reversal from May lows indicates capitulation: The 16.8% recovery from $32.17 over six sessions following the -19.21% YTD decline suggests selling exhaustion and potential valuation floor establishment at current levels.

Bear Case

• Brand dilution risk from mainstream expansion: The explicit challenge of maintaining performance identity while pursuing mass-market growth through celebrity partnerships and apparel diversification mirrors the trajectory that damaged Nike and Allbirds. Source
• Workforce tripling since IPO suggests organizational complexity: Rapid headcount expansion from IPO to present creates integration challenges, communication overhead, and potential culture dilution that the dual-CEO structure may not adequately address. Source
• -19.21% YTD decline reflects sustained selling pressure: The persistent year-to-date weakness despite recent recovery indicates structural concerns about valuation, growth sustainability, or competitive positioning that six sessions of gains have not resolved.
• Premium pricing vulnerable in uncertain economic environment: Performance footwear at premium price points faces demand elasticity risk if consumer spending contracts, with On's positioning at the high end of the market creating downside exposure.
• Dual-CEO structure introduces execution complexity: The leadership transition to two co-chief executives, while intended to preserve agility, creates potential for decision-making friction and accountability dilution during critical scaling phase. Source